Absorption |
Blood-Brain Barrier | BBB- | 0.8933 |
Human Intestinal Absorption | HIA+ | 0.9945 |
Caco-2 Permeability | Caco2- | 0.8398 |
P-glycoprotein Substrate | Substrate | 0.6957 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8938 |
Non-inhibitor | 0.9060 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8002 |
Distribution |
Subcellular localization | Lysosome | 0.4760 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6935 |
CYP450 2D6 Substrate | Non-substrate | 0.7269 |
CYP450 3A4 Substrate | Non-substrate | 0.6115 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8392 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8444 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8409 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8229 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6552 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7846 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8635 |
Non-inhibitor | 0.7699 |
AMES Toxicity | Non AMES toxic | 0.7787 |
Carcinogens | Non-carcinogens | 0.8711 |
Fish Toxicity | High FHMT | 0.9537 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9632 |
Honey Bee Toxicity | Low HBT | 0.5832 |
Biodegradation | Not ready biodegradable | 0.9757 |
Acute Oral Toxicity | III | 0.7006 |
Carcinogenicity (Three-class) | Non-required | 0.6048 |